As the Delta variant spreads, COVID-19 cases are rising in parts of the U.S. that have low vaccination rates. Some 1,600 counties in 40 states have vaccination rates lower than 40%. (CNBC Weekly)

The Food and Drug Administration has raised safety and efficacy concerns over FibroGen’s anemia drug roxadustat. Experts had previously flagged potential issues in the drug’s cardiovascular safety data. (Endpoints News)

Related Cos. will partner with healthcare provider CareMax to develop senior health centers in underserved communities, potentially opening 75 locations in the next three years. “The seniors that need it the most are in tougher areas,” CareMax chief executive and founder Carlos de Solo said. (The Wall Street Journal)

As the pandemic slows in the U.S., state emergency declarations and policies that allowed for easy access to virtual care are being phased out. Rules that render telemedicine less accessible are returning, creating barriers for doctors and patients alike. (STAT)

Zimbabwe president Emmerson Mnangagwa announced a goal to vaccinate 1 million people in the next two weeks. Some 900,000 people have thus far received their first dose, but cases are rising at an “alarming rate.” (Reuters)